Edition:
United Kingdom

China Resources Pharmaceutical Group Ltd (3320.HK)

3320.HK on Hong Kong Stock

10.48HKD
1:40am GMT
Change (% chg)

HK$0.04 (+0.38%)
Prev Close
HK$10.44
Open
HK$10.44
Day's High
HK$10.50
Day's Low
HK$10.40
Volume
103,000
Avg. Vol
7,761,902
52-wk High
HK$11.18
52-wk Low
HK$8.37

Latest Key Developments (Source: Significant Developments)

China Resources Double-crane Pharmaceutical unit receives GMP certificate
Wednesday, 24 Jan 2018 

Jan 24 (Reuters) - China Resources Double-crane Pharmaceutical Co Ltd <600062.SS>:Says wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Henan Food and Drug Administration .Certificate issued to edaravone manufactured by the unit and the valid period is until Jan. 7, 2023 .  Full Article

China Resources Pharmaceutical Announces Proposed Capital Contribution To CR Leasing
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::UNITS, ENTERS CAPITAL CONTRIBUTION AGREEMENT WITH CR LEASING (HONG KONG) & CR LEASING.DEAL FOR PROPOSED CAPITAL CONTRIBUTION OF RMB 889.4 MILLION​.  Full Article

China Resources Pharmaceutical Group Declares Special Dividend
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::RESOLVED TO DECLARE SPECIAL DIVIDEND IN AMOUNT OF HK$668.3 MILLION.  Full Article

China Resources Pharmaceutical Group's units enter agreement to establish fund
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>:Units of co enter agreement with other partners in relation to establishment of fund of RMB2,500 million​.‍Proposed aggregate capital commitment of group to fund RMB305.25 million​.  Full Article

China Resources Pharmaceutical says 9-mnth net profit RMB970.2 mln ​‍​
Monday, 30 Oct 2017 

Oct 30 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>:9-month net profit RMB970.2 million versus RMB878.2 million ‍a year ago​.9-mnth ‍revenue RMB7.48 billion versus RMB6.16 billion ​‍​.  Full Article

China Resources Double-crane Pharmaceutical to set up medical industrial investment LP with partners
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - China Resources Double-crane Pharmaceutical Co Ltd <600062.SS> ::Says it plans to invest 50 million yuan to set up an medical industrial investment limited partnership worth totaling 2.5 billion yuan, with partners.  Full Article

China Resources Pharmaceutical updates on formation of fund
Tuesday, 24 Oct 2017 

Oct 25 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>:Unit under discussion with CR Capital GP, CR Capital LP, CR Sanjiu and CR Double-Crane​.Discussions ‍in relation to formation of fund with proposed size of RMB2,500 million​.‍Proposed aggregate capital commitment of group will amount to RMB305.25 million​.‍Initial duration of fund will be five (5) years commencing from date of incorporation of fund​.  Full Article

China Resources Pharmaceutical applies for Hong Kong listing
Monday, 27 Jun 2016 

China Resources Pharmaceutical Group Ltd [IPO-CNRS.HK] :China Resources Pharmaceutical Group Ltd has applied for listing on Hong Kong stock exchange - HKEx filing.  Full Article